ROARABLE
Today ⌘ Pro Terminal Big Ideas 🎲 Predictions Screener 🦋 Butterfly 8 Analysts 🏛️ Policy 🎬 Video ★ Watchlist 🎲 Prediction Markets 📊 RQD Track Record 📅 Next Catalysts 🛡️ Overlap & Crash X-Ray 📰 Live Wire 🐋 13F Whales 🏛️ Congress & CEO Buys 🏆 $100K Arena ⌘ Pro Terminal 📐 Methodology & Corrections
Stock Ratings / Health Care / PLSM / earnings
FEMY (30) ICU (31) SINT (33) CNSY (25) ⌘ Pro Terminal →

Pulsenmore Ltd. (PLSM) Next Earnings Date & Expected ±12.5% Move

$1.67 +3.09% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.68

Pulsenmore Ltd. (PLSM) carries a Roarable Rating of D (Sell) with 47/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →
ROARABLE D • SELL / AVOID Cap $10.9M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on PLSM Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is PLSM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Pulsenmore Ltd. (NASDAQ: PLSM) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $1.67 (+3.09% 1D, market cap $10.9M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, PLSM ranks #317 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does PLSM compare to FEMY and ICU in the Health Care sector?
▼

Within the Health Care sector (Medical/Dental Instruments), PLSM carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, FEMY (Femasys Inc.) holds a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $11.5M) and ICU (SeaStar Medical Holding Corporation) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $11.8M). Among the 5-stock peer group, PLSM leads on earnings multiple (N/A) while FEMY leads on capital efficiency (-35.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for PLSM?
▼

For Pulsenmore Ltd. (PLSM), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #317 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.68 (+0.37%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510047
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+
Cash (12)Whales (3)SEC (13)Macro (10)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-4.8% Base Target
$14 Bull$2 Base$1 Bear
📬 FREE PLSM RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PLSM)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (47/100 Composite)
🔍 WHY PLSM SCORES 47/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (28% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)

SEC XBRL Trailing 12 Months: 0% FCF Margin ($304.1K FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
55
Grade C$1.90-7.4% Next Q
Q2 (-2Q)
52
Grade C-$1.76+1.7% Next Q
Q3 (-1Q)
50
Grade C-$1.79-6.7% Next Q
Current
47
Grade D$1.67-5.9% Hist 90D α
Trajectory: C (55) → D (47)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a PLSM Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While PLSM currently carries a cautious 47/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.17) and Max Pain ($1.75) forces dealer call-delta covering toward $13.62.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $PLSM• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PLSM Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
YES 47%NO 53%Trade / Inspect Odds →
NEXT EST. WINDOW: Upcoming Quarter (~28 DAYS)

Historical OHLCV Volatility ±12.5% Swing Band

±$0.21 Expected Swing
$1.46 (-12.5%)Spot $1.67$1.88 (+12.5%)
MODEL EARNINGS SETUP GAUGE

PLSM Quantitative Pre-Earnings Setup: 47/100

Trailing EPS: $4.25 • YoY Revenue Growth: 12.4%

Model Bullish Setup (47/100)Model Risk Weight (53/100)
Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).
LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PLSM)

  • ✓Walkthrough of PLSM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
PLSM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -50.45%⚡ TESTING RESISTANCE
2026-11-03O $1.62H $1.67L $1.62C $1.67VOL 11.3K
RES: $1.71SUP: $1.53SMA50: $2.17SMA200: $3.71
$13.77$10.46$7.16$3.85$0.54RES $1.71SUP $1.53$1.672026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PLSM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PLSM Butterfly Map → + Track PLSM →
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PLSM today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PLSM. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PLSM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PLSM)

Health Care Rank #317 of 1016 ⚔️ FEMY vs PLSM Full Matrix →

1. Head-to-Head Health Care Peer Comparison (PLSM vs. FEMY, ICU, SINT, CNSY)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Pulsenmore Ltd. (PLSM) ranks #317 by composite RQD confidence (47/100, grade D) and #888 by equity capitalization ($10.9M). Within this direct 5-issuer industry benchmark cohort, PLSM leads on earnings valuation at N/A trailing P/E, while FEMY leads on capital efficiency and profitability with -35.0% ROIC and 62.0% gross margin. PLSM currently leads its immediate peer cohort in composite quantitative strength at 47/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
PLSM ACTIVE
Pulsenmore Ltd.
D 47/100 — — — +3.09% $10.9M Benchmark Subject
FEMY
Femasys Inc.
E 30/100 — 62.0% -35.0% +1.11% $11.5M /femy-vs-plsm →
ICU
SeaStar Medical Holding Corporation
E 31/100 — 95.7% -35.0% -3.03% $11.8M /icu-vs-plsm →
SINT
SiNtx Technologies Inc.
E 33/100 — 45.3% -35.0% -1.16% $12.8M /sint-vs-plsm →
CNSY
Cerenome Inc.
E 25/100 — — -35.0% -2.30% $12.9M /cnsy-vs-plsm →

2. PLSM Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Pulsenmore Ltd. (PLSM) operates in Medical/Dental Instruments (Health Care) with an equity capitalization of $10.9M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. PLSM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is PLSM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Pulsenmore Ltd. (NASDAQ: PLSM) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $1.67 (+3.09% 1D, market cap $10.9M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, PLSM ranks #317 in composite RQD confidence.

How does PLSM compare to FEMY and ICU in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), PLSM carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, FEMY (Femasys Inc.) holds a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $11.5M) and ICU (SeaStar Medical Holding Corporation) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $11.8M). Among the 5-stock peer group, PLSM leads on earnings multiple (N/A) while FEMY leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for PLSM?

For Pulsenmore Ltd. (PLSM), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #317 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is PLSM trading relative to its 50-day, 200-day, and 52-week technical levels?

PLSM last traded at $1.67 (+3.09% on volume of 11,325 shares), positioning the stock -23.04% below its 50-day simple moving average ($2.17) and -54.99% below its 200-day simple moving average ($3.71). Across its 52-week range of $1.57 to $12.97, PLSM sits at the 0.9% percentile with a 14-day RSI of 34.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.46 to $1.88).

PLSM Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is PLSM's next earnings date?

Based on SEC filing cadence, Pulsenmore Ltd. (PLSM)'s next quarterly reporting window is estimated around Upcoming Quarter.

How much is PLSM stock expected to move on earnings?

Volatility modeling currently projects a ±12.5% event move for PLSM, spanning a range between $1.46 and $1.88.

Direct Sub-Reports: PLSM RQD Cockpit PLSM 12M Forecast PLSM Earnings & Move PLSM Dividends & DRIP PLSM Insiders & 13F PLSM Whale Options PLSM Profit Sankey PLSM News & Why
ROARABLE RATING BRIEF • RQD 47/100 (D) ✓ STAGE-C NUMBER FIREWALL VERIFIED

PLSM — Pulsenmore Ltd.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T14:20:08Z

Roarable Rating Brief: What This Means to a Prospective Investor

The Roarable RQD rating is 47 out of 100, graded D, with the verdict "Roarable Sell — Underperform / Distribution Warning" (per the Roarable RQD rating). The five pillars are:

  • Fundamental Cash Engine: 12 / 20. Per the Roarable RQD rating, this pillar reflects ROIC of 0% and FCF yield of 0%. For a prospective investor, the absence of measured return on capital and free-cash-flow yield means the pillar offers no cash-generation evidence to support valuation.
  • Whale 13F Flow: 3 / 20. This pillar covers institutional accumulation and options positioning. Scoring 3 of 20 is the weakest pillar and signals little institutional support in the source data.
  • Insider Conviction: 9 / 20. This pillar reflects SEC Form 4 and Congressional PTR cluster flow. A 9 of 20 score indicates limited insider-conviction signal.
  • Macro Regime Fit: 10 / 20. Per the Roarable RQD rating, beta is 1.0 and the score reflects sector sensitivity. A beta of 1.0 means the stock is modeled to move in line with the market; the score indicates limited macro-regime tailwind.
  • Forensic Balance Sheet: 13 / 20. Per the Roarable RQD rating, Altman Z is 2.5, Piotroski F is 6/9, and Debt/Equity is 0.5. This is the strongest pillar, indicating a comparatively steadier balance-sheet profile than the cash and flow pillars.

Taken together, the rating points to weak cash generation and weak institutional and insider support, partly offset by a relatively better balance-sheet reading. An investor weighing valuation tradeoffs would have limited measured earnings or cash-flow anchor for the current price of $1.62 (per the market data), which is down 8.48% (per the market data) and sits near the bottom of its 52-week range of $1.57 - $12.97 (per the market data). This is an analytical summary, not personalized advice.

PLSM Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Pulsenmore Ltd. (PLSM) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to PLSM Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

PLSM Bull vs. Bear Conversation Board — What's Your Call at $1.67?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON PLSM 🐻 50% BEARISH CONVICTION
1. Pick Your Side on PLSM:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $1.75 (+8.0%)
📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is PLSM (D • RQD 47/100) a Buy at $1.62?

Welcome to the PLSM (Pulsenmore Ltd.) Roar Pit. Current RQD Composite is 47/100 (Roarable Sell — Underperform / Distribution Warning) in Medical/Dental Instruments. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $1.22 (-24.7%)
Spot @ $1.62

Pump the brakes on PLSM — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on PLSM, but look at what you are paying: current EV/EBITDA multiples with tightening sector spreads. Unless Pulsenmore Ltd. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

QU QuantViper Verified K Arena Trader 🐂 BULLISH 🎯 Target: $1.91 (+17.9%)
Spot @ $1.62

PLSM cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on PLSM, the market is fixating on short-term headline noise in Medical/Dental Instruments and ignoring the balance sheet and cash flow trajectory. At $1.62 (52-wk range $1.57 - $12.97), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%